Chemistry42

Platform

Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.

Find alternatives to Chemistry42

TypePlatform
RoleStandalone tool
AvailabilitySold
DeploymentSaaS
Intended forResearcher
SecurityVendor-asserted
CertificationsISO/IEC 27001
Trains on customer dataUnknown
Zero data retentionUnknown
Data residencyCustom region
Security featuresEncryption at rest
StatusActive
Sold withinSold on its own
PricingSubscription, Enterprise quote — official pricing ↗

What it does

Features 7

pharma.ai

Sources

Pricing

Official documentation · 3 Sep 2026

Billing-period toggle visible on product page; access is request-gated rather than self-serve.

Constraints

Official documentation · 2 Oct 2026

Derived from the security facts on this page, from the same source.

Security

Official documentation · 2 Oct 2026

Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.

Sold within

Official documentation · 15 Sep 2026

pharma.ai/chemistry42 (already cited official-docs elsewhere on this record); offered standalone, no packaging restriction stated.

Intended for

Self-reported · 8 Sep 2026

Trained on "the medicinal chemists' reaction toolbox"; positioned as a drug-discovery platform for hit identification/lead optimization used by medicinal/computational chemists.

Also from Insilico Medicine

Open Insilico Medicine in the directory

Something wrong here? Send a correction — quote this product id: insilico-medicine-chemistry42.